Relay Therapeutics Inc (RLAY)

EBITDA Margin

-2742.28%

TTM · Period ending:

RLAY logo

RLAY EBITDA Margin

Latest reported-2742.28%
RLAY TTM EBITDA Margin (-62.86% → -2742.28%)
High-resolution chart · PNG

RLAY ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Relay Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-2,742.2802%
-2,527.4141%
-1,777.2988%
-3,510.0646%
-3,669.6745%
-4,532.2047%
-3,627.171%
-3,809.6042%
-1,044.8336%
-1,030.2884%
-1,464.6246%
-1,408.8915%
-39,456.1571%
-28,742.7609%
-22,217.3787%
-17,082.3598%
-13,184.2835%
-9,897.3157%
-7,335.1601%
-142.2071%
-116.9414%
-81.1497%
-62.8633%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.